FLEMINGTON, N.J.--(BUSINESS WIRE)--July 5, 2006--NovaDel Pharma (AMEX: NVD - News) today announced the submission of the New Drug Application (NDA) for Zensana(TM) (Ondansetron HCl) Oral Spray to the US Food and Drug Administration (FDA) by its partner Hana Biosciences.
